DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Walnut Creek, CA

22 verified pulmonary disease doctors in Walnut Creek.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Medical Board of California

Dr. Nader Kamangar, MD

Pulmonary Disease

21 yrs NPPES
NPI 1922093285
1399 YGNACIO VALLEY RD, STE 14, Walnut Creek, CA 94598(925) 939-3050
NPPES public registry
CMS Open Payments· $262.79 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$262.79

Total received

9

Transactions

8

Paying companies

Top paying companies

Amgen Inc.$47.67
Boehringer Ingelheim Pharmaceuticals, Inc.$44.25
Merck Sharp & Dohme LLC$34.94
Baxter Healthcare$34.69
Astellas Pharma US Inc$33.46
Olympus America Inc.$30.39

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 67th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Nader Kamangar do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Aamir Faruqui, MD

Pulmonary Disease

21 yrs NPPES
NPI 1184619447
2121 YGNACIO VALLEY RD, SUITE E 104, Walnut Creek, CA 94598(925) 934-2121
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,055 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,055

Total received

33

Transactions

9

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$280.33
Jazz Pharmaceuticals Inc.$235.16
AstraZeneca Pharmaceuticals LP$215.56
Harmony Biosciences LLC$201.68
GlaxoSmithKline, LLC.$41.34
Axsome Therapeutics, Inc.$30.94

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 80th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Aamir Faruqui do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Ramin Khashayar, MD

Pulmonary Disease

21 yrs NPPES
NPI 1003801358
1399 YGNACIO VALLEY RD, STE 14, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $956.13 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$956.13

Total received

25

Transactions

10

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$266.63
AstraZeneca Pharmaceuticals LP$177.54
Inari Medical, Inc.$173.34
GlaxoSmithKline, LLC.$163.96
Takeda Pharmaceuticals U.S.A., Inc.$59.22
Mylan Specialty L.P.$39.32

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Ramin Khashayar do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Valerie Schneider, MD

Pulmonary Disease

21 yrs NPPES
NPI 1689669830
1600 S MAIN ST STE 145, Walnut Creek, CA 94596(925) 933-3194
NPPES public registry
CMS Open Payments· $53.11 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$53.11

Total received

2

Transactions

1

Paying companies

Top paying companies

AbbVie Inc.$53.11

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 54th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Valerie Schneider do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Eric Buadu, MD

Pulmonary Disease

21 yrs NPPES
NPI 1316932965
1601 YGNACIO VALLEY RD, JOHN MUIR MEDICAL CENTER, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Kristina Kramer, MD

Pulmonary Disease

20 yrs NPPES
NPI 1598714511
2637 SHADELANDS DR, Walnut Creek, CA 94598(925) 932-6330
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,283 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,283

Total received

62

Transactions

10

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$426.84
AstraZeneca Pharmaceuticals LP$318.63
GlaxoSmithKline, LLC.$231.05
Takeda Pharmaceuticals U.S.A., Inc.$82.06
Baxter Healthcare$70.69
United Therapeutics Corporation$39.67

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kristina Kramer do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Ka Ling (Karin) Cheung, MD

Pulmonary Disease

20 yrs NPPES
NPI 1881643831
2637 SHADELANDS DR, Walnut Creek, CA 94598(925) 944-0166
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $3,012 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,012

Total received

137

Transactions

23

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$489.08
Boehringer Ingelheim Pharmaceuticals, Inc.$408.25
AstraZeneca Pharmaceuticals LP$293.27
Vanda Pharmaceuticals Inc.$205.28
Harmony Biosciences LLC$200.06
Baxter Healthcare$198.92

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 89th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Ka Ling (Karin) Cheung do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Harry Macdannald, MD

Pulmonary Disease

20 yrs NPPES
NPI 1306895313
130 LA CASA VIA, BLDG #2, SUITE 208, Walnut Creek, CA 94598(925) 944-0166
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,077 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,077

Total received

44

Transactions

15

Paying companies

Top paying companies

Inspire Medical Systems, Inc.$176.88
GlaxoSmithKline, LLC.$171.45
ResMed Corp$136.86
Harmony Biosciences LLC$130.04
Jazz Pharmaceuticals Inc.$113.84
Regeneron Healthcare Solutions, Inc.$102.99

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 80th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Harry Macdannald do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Michael Cohen, MD

Pulmonary Disease

20 yrs NPPES
NPI 1205885779
130 LA CASA VIA, BLDG #2, SUITE 208, Walnut Creek, CA 94598(925) 944-0166
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $591.34 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$591.34

Total received

19

Transactions

8

Paying companies

Top paying companies

Inspire Medical Systems, Inc.$184.12
ResMed Corp$136.86
Jazz Pharmaceuticals Inc.$92.88
GlaxoSmithKline, LLC.$60.64
Harmony Biosciences LLC$42.68
Axsome Therapeutics, Inc.$30.80

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 75th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Michael Cohen do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Elvio Ardilles, MD

Pulmonary Disease

20 yrs NPPES
NPI 1518905322
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $666.23 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$666.23

Total received

14

Transactions

11

Paying companies

Top paying companies

Inari Medical, Inc.$173.34
CoapTech, Inc.$147.64
Actelion Pharmaceuticals US, Inc.$110.28
Takeda Pharmaceuticals U.S.A., Inc.$59.22
Boehringer Ingelheim Pharmaceuticals, Inc.$30.90
GlaxoSmithKline, LLC.$28.89

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Elvio Ardilles do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Vala Berjis, MD

Pulmonary Disease

19 yrs NPPES
NPI 1023135761
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $931.41 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$931.41

Total received

10

Transactions

6

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$245.45
AstraZeneca Pharmaceuticals LP$210.47
Inari Medical, Inc.$173.34
CoapTech, Inc.$147.64
Boehringer Ingelheim Pharmaceuticals, Inc.$112.39
Janssen Pharmaceuticals, Inc$42.12

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Vala Berjis do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Ming-Tyh Maa, MD

Pulmonary Disease

19 yrs NPPES
NPI 1073718722
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $3,867 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,867

Total received

49

Transactions

17

Paying companies

Top paying companies

Olympus Corporation of the Americas$1,444
Intuitive Surgical, Inc.$1,183
AstraZeneca Pharmaceuticals LP$291.38
Pulmonx Corporation$170.36
CoapTech, Inc.$147.64
Ethicon Inc.$131.98

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Ming-Tyh Maa do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kelvin Shiu, DO

Pulmonary Disease

19 yrs NPPES
NPI 1073719381
1425 S MAIN ST, Walnut Creek, CA 94596(925) 295-4000
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Jamal Zaka, MD

Pulmonary Disease

18 yrs NPPES
NPI 1053581769
130 LA CASA VIA, #208, Walnut Creek, CA 94598(925) 944-0166
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $258.91 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$258.91

Total received

11

Transactions

2

Paying companies

Top paying companies

Inspire Medical Systems, Inc.$221.99
Itamar Medical Inc$36.92

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 67th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jamal Zaka do not imply any wrongdoing. Many are meals, education, or research support.

Dr. George Juan, MD

Pulmonary Disease

15 yrs NPPES
NPI 1619273364
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,028 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,028

Total received

22

Transactions

13

Paying companies

Top paying companies

Pulmonx Corporation$1,309
AstraZeneca Pharmaceuticals LP$149.30
CoapTech, Inc.$147.64
Ethicon Inc.$118.15
Intuitive Surgical, Inc.$96.88
Inari Medical, Inc.$39.69

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to George Juan do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jigar Patel, MD

Pulmonary Disease

14 yrs NPPES
NPI 1356699417
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $209.13 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$209.13

Total received

3

Transactions

2

Paying companies

Top paying companies

Inari Medical, Inc.$190.28
Mylan Specialty L.P.$18.85

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 65th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jigar Patel do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Nick Pakzad, MD

Pulmonary Disease

13 yrs NPPES
NPI 1316280555
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Andrew Chu, MD

Pulmonary Disease

12 yrs NPPES
NPI 1861816639
1425 S MAIN ST, Walnut Creek, CA 94596(925) 295-4000
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Amish Shah, MD

Pulmonary Disease

11 yrs NPPES
NPI 1376920884
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $679.24 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$679.24

Total received

19

Transactions

8

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$341.63
Inari Medical, Inc.$150.59
Pulmonx Corporation$81.37
GlaxoSmithKline, LLC.$25.68
Baxter Healthcare$23.33
AbbVie Inc.$20.63

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Amish Shah do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mark Slootsky, MD

Pulmonary Disease

11 yrs NPPES
NPI 1396124749
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $363.44 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$363.44

Total received

5

Transactions

3

Paying companies

Top paying companies

Inari Medical, Inc.$173.34
CoapTech, Inc.$147.64
Boehringer Ingelheim Pharmaceuticals, Inc.$42.46

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mark Slootsky do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Matthew Lyons, MD

Pulmonary Disease

10 yrs NPPES
NPI 1457714933
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,359 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,359

Total received

16

Transactions

7

Paying companies

Top paying companies

Medical Device Business Services, Inc.$1,036
Ethicon Inc.$109.08
Intuitive Surgical, Inc.$96.89
Inari Medical, Inc.$39.69
Merck Sharp & Dohme LLC$28.92
GlaxoSmithKline, LLC.$26.92

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Matthew Lyons do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Anne Grzegorczyk, MD

Pulmonary Disease

10 yrs NPPES
NPI 1720434004
2700 YGNACIO VALLEY RD STE 100, Walnut Creek, CA 94598(925) 939-3050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $181.48 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$181.48

Total received

2

Transactions

2

Paying companies

Top paying companies

CoapTech, Inc.$147.64
Boehringer Ingelheim Pharmaceuticals, Inc.$33.84

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 64th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Anne Grzegorczyk do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Walnut Creek, CA — Verified | DoctorsProof | DoctorsProof